Metraipolis › archive › dc_beabbd6f43e7

Garadacimab and the future of hereditary angioedema prophylaxis: a step upstream in the bradykinin pathway — Europe PMC PMID:42433832

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42433832
DOI
10.1097/ms9.0000000000005029
License (as archived)
solo-consultazione
Archived
2026-10-31T19:40:58.686Z
SHA-256 of the archived text
73edb2978e18f4a8423070ce7a0d38c9be72eaf93ca2b1d4e46f5e3ee5f076bd
Stable URL of this page
https://metraipolis.com/documento/dc_beabbd6f43e7

How to cite

Garadacimab and the future of hereditary angioedema prophylaxis: a step upstream in the bradykinin pathway — Europe PMC PMID:42433832 — Europe PMC (en), https://europepmc.org/article/MED/42433832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beabbd6f43e7 (Metraipolis archive dc_beabbd6f43e7, sha256 73edb2978e18f4a8423070ce7a0d38c9be72eaf93ca2b1d4e46f5e3ee5f076bd)
BibTeX
@misc{dcbeabbd6f43e7,
  title = {Garadacimab and the future of hereditary angioedema prophylaxis: a step upstream in the bradykinin pathway — Europe PMC PMID:42433832},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42433832},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beabbd6f43e7; sha256 73edb2978e18f4a8423070ce7a0d38c9be72eaf93ca2b1d4e46f5e3ee5f076bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433832. Agents can read the archived copy with the MCP tool read_document.